SAM
MRNA icon

Smartleaf Asset Management’s Moderna MRNA Stock Holding History

Smartleaf Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.9K Hold
960
– – ﹤0.01% 1367
2026
Q1 		$46.3K Buy
960
+134
+16% +$6.25K ﹤0.01% 1498
2025
Q4 		$25.1K Sell
826
-77
-9% -$2.09K ﹤0.01% 1907
2025
Q3 		$22.9K Buy
903
+719
+391% +$20.1K ﹤0.01% 1759
2025
Q2 		$5K Sell
184
-328
-64% -$8.64K ﹤0.01% 2050
2025
Q1 		$15.9K Sell
512
-51
-9% -$1.81K ﹤0.01% 1727
2024
Q4 		$22.2K Sell
563
-476
-46% -$22.8K ﹤0.01% 1591
2024
Q3 		$68.3K Buy
1,039
+460
+79% +$42.2K 0.01% 814
2024
Q2 		$70.2K Sell
579
-34
-6% -$4.3K 0.01% 660
2024
Q1 		$67.8K Buy
613
+560
+1,057% +$56.4K 0.01% 608
2023
Q4 		$5.23K Buy
+53
New +$4.46K ﹤0.01% 860

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Smartleaf Asset Management's MRNA Position: Q2 2026 in Review

Smartleaf Asset Management held its Moderna (MRNA) position steady in Q2 2026 at 960 shares worth $66.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1367.

Smartleaf Asset Management first reported a position in MRNA in Q4 2023 and has held it in 11 quarters since. The position peaked at $70.2K in Q2 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Smartleaf Asset Management held 960 shares of Moderna worth $66.9K as of Q2 2026.
  • Smartleaf Asset Management left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1367 holding.
  • Smartleaf Asset Management first reported a position in Moderna in Q4 2023 and has held it in 11 quarters since.
  • Smartleaf Asset Management's Moderna position peaked at $70.2K in Q2 2024.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.